Wedbush Equities Analysts Boost Earnings Estimates for ASND
Ascendis Pharma A/S (NASDAQ:ASND – Free Report) – Equities researchers at Wedbush lifted their FY2029 EPS estimates for Ascendis Pharma A/S in a note issued to investors on Thursday, May 1st. Wedbush analyst Y. Zhong now forecasts that the biotechnology company will post earnings per share of $14.91 for the year, up from their previous […]
Ascendis Pharma A/S (NASDAQ:ASND – Free Report) – Equities researchers at Wedbush lifted their FY2029 EPS estimates for Ascendis Pharma A/S in a note issued to investors on Thursday, May 1st. Wedbush analyst Y. Zhong now forecasts that the biotechnology company will post earnings per share of $14.91 for the year, up from their previous […]
